{"id":181282,"name":"BIOTECHNOLOGY INDUSTRY ORGANIZATION","slug":"biotechnology-industry-organization","state":"DC","country":"United States of America","description":"","totalSpending":2800000,"filings":35,"yearlySpending":[{"year":2018,"income":320000},{"year":2019,"income":320000},{"year":2020,"income":320000},{"year":2021,"income":400000},{"year":2022,"income":400000},{"year":2023,"income":400000},{"year":2024,"income":320000},{"year":2025,"income":320000}],"issues":[{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"}],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["RAISSA DOWNS","JENNIFER YOUNG","MICHELLE EASTON","ELIZABETH MURRAY","CHARLOTTE IVANCIC","PAMELA SMITH","EMILY MURRY","KIMBERLY BRANDT","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","Office of Management & Budget (OMB)","SENATE"],"sampleDescriptions":["pharmaceutical tax, orphan drug tax credit","budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018","PL 114-255 - 21st Century Cures, implementation\nS. 456 - RACE for Children Act\nS. 771 - Improving Access to Affordable Prescription Drugs Act\nS. 637 - Creating Transparency to Have Drug Rebates Unlock","Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, biosimilars, 340B, Sunshine, discount cards, MedPAC, coding, ASP, Part B, donut hole, P","PL 114-255 - 21st Century Cures, implementation\nH.R. 2430 - FDA Reauthorization Act of 2017\n\n\n***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrit"]}